NO313196B1 - Pyrimidinylpyrazol-derivat, og antitumormiddel inneholdende dette - Google Patents
Pyrimidinylpyrazol-derivat, og antitumormiddel inneholdende dette Download PDFInfo
- Publication number
- NO313196B1 NO313196B1 NO19971384A NO971384A NO313196B1 NO 313196 B1 NO313196 B1 NO 313196B1 NO 19971384 A NO19971384 A NO 19971384A NO 971384 A NO971384 A NO 971384A NO 313196 B1 NO313196 B1 NO 313196B1
- Authority
- NO
- Norway
- Prior art keywords
- group
- hydrochloride
- methyl
- pyrimidinyl
- pyrazolyl
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title claims description 11
- BWIHJLOBZMKPKS-UHFFFAOYSA-N 2-(1h-pyrazol-5-yl)pyrimidine Chemical class N1C=CC(C=2N=CC=CN=2)=N1 BWIHJLOBZMKPKS-UHFFFAOYSA-N 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 105
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 20
- 125000005843 halogen group Chemical group 0.000 claims abstract description 14
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 6
- 125000003277 amino group Chemical group 0.000 claims abstract description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 3
- 125000001424 substituent group Chemical group 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 12
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 7
- 125000004429 atom Chemical group 0.000 claims description 7
- 125000003282 alkyl amino group Chemical group 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 1
- 230000000259 anti-tumor effect Effects 0.000 abstract description 9
- 125000003545 alkoxy group Chemical group 0.000 abstract description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 94
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 72
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 65
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- 239000002904 solvent Substances 0.000 description 53
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 40
- 239000007864 aqueous solution Substances 0.000 description 36
- 238000001704 evaporation Methods 0.000 description 32
- 230000008020 evaporation Effects 0.000 description 32
- 229920006395 saturated elastomer Polymers 0.000 description 32
- 238000000034 method Methods 0.000 description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
- 239000000203 mixture Substances 0.000 description 30
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 29
- 239000000243 solution Substances 0.000 description 28
- 238000005160 1H NMR spectroscopy Methods 0.000 description 27
- 238000010992 reflux Methods 0.000 description 25
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 20
- 239000011780 sodium chloride Substances 0.000 description 20
- 238000005481 NMR spectroscopy Methods 0.000 description 17
- 238000010626 work up procedure Methods 0.000 description 17
- -1 lithium aluminum hydride Chemical compound 0.000 description 15
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 238000010898 silica gel chromatography Methods 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 12
- 235000017557 sodium bicarbonate Nutrition 0.000 description 12
- 239000012279 sodium borohydride Substances 0.000 description 12
- 229910000033 sodium borohydride Inorganic materials 0.000 description 12
- 229930040373 Paraformaldehyde Natural products 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 229920002866 paraformaldehyde Polymers 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000011877 solvent mixture Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- UMOPUYQHCRDESJ-UHFFFAOYSA-N 1-(5-methyl-1-pyrimidin-2-ylpyrazol-4-yl)ethanone Chemical compound CC1=C(C(=O)C)C=NN1C1=NC=CC=N1 UMOPUYQHCRDESJ-UHFFFAOYSA-N 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- MGFREDWKELGWML-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinolin-2-ium;chloride Chemical compound [Cl-].C1=CC=C2C[NH2+]CCC2=C1 MGFREDWKELGWML-UHFFFAOYSA-N 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000005456 alcohol based solvent Substances 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- 239000004210 ether based solvent Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine group Chemical group P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
- YMDZDFSUDFLGMX-UHFFFAOYSA-N 2-chloro-n-(2-chloroethyl)ethanamine;hydron;chloride Chemical compound [Cl-].ClCC[NH2+]CCCl YMDZDFSUDFLGMX-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 150000007514 bases Chemical class 0.000 description 3
- 150000008282 halocarbons Chemical class 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- LHJNEDCRXXPMKC-UHFFFAOYSA-N 1-(2,5-dichlorophenyl)piperazine;hydrochloride Chemical compound Cl.ClC1=CC=C(Cl)C(N2CCNCC2)=C1 LHJNEDCRXXPMKC-UHFFFAOYSA-N 0.000 description 2
- GVMWPBSQIFCFKV-UHFFFAOYSA-N 1-(2,5-difluorophenyl)piperazine;hydrochloride Chemical compound Cl.FC1=CC=C(F)C(N2CCNCC2)=C1 GVMWPBSQIFCFKV-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000006683 Mannich reaction Methods 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- WFDACDHNFNKJJJ-UHFFFAOYSA-N 1-(2-chloro-3-methylphenyl)piperazine;hydrochloride Chemical compound Cl.CC1=CC=CC(N2CCNCC2)=C1Cl WFDACDHNFNKJJJ-UHFFFAOYSA-N 0.000 description 1
- PWZDJIUQHUGFRJ-UHFFFAOYSA-N 1-(2-chlorophenyl)piperazine Chemical compound ClC1=CC=CC=C1N1CCNCC1 PWZDJIUQHUGFRJ-UHFFFAOYSA-N 0.000 description 1
- JVQOFQHGEFLRRQ-UHFFFAOYSA-N 1-(2-fluorophenyl)piperazine;hydrochloride Chemical compound Cl.FC1=CC=CC=C1N1CCNCC1 JVQOFQHGEFLRRQ-UHFFFAOYSA-N 0.000 description 1
- LZNYIWJDVYCKDU-UHFFFAOYSA-N 1-(2-methylphenyl)piperazine;hydrochloride Chemical compound Cl.CC1=CC=CC=C1N1CCNCC1 LZNYIWJDVYCKDU-UHFFFAOYSA-N 0.000 description 1
- GJASZYGGGRNXFT-UHFFFAOYSA-N 1-(3,5-dichlorophenyl)piperazine;hydrochloride Chemical compound Cl.ClC1=CC(Cl)=CC(N2CCNCC2)=C1 GJASZYGGGRNXFT-UHFFFAOYSA-N 0.000 description 1
- NBELRSAJZMPNCR-UHFFFAOYSA-N 1-(3,5-difluorophenyl)piperazine;hydrochloride Chemical compound Cl.FC1=CC(F)=CC(N2CCNCC2)=C1 NBELRSAJZMPNCR-UHFFFAOYSA-N 0.000 description 1
- DOYNABJKDZARLF-UHFFFAOYSA-N 1-(3-bromophenyl)piperazine Chemical compound BrC1=CC=CC(N2CCNCC2)=C1 DOYNABJKDZARLF-UHFFFAOYSA-N 0.000 description 1
- MHXPYWFZULXYHT-UHFFFAOYSA-N 1-(3-chlorophenyl)piperazin-1-ium;chloride Chemical compound Cl.ClC1=CC=CC(N2CCNCC2)=C1 MHXPYWFZULXYHT-UHFFFAOYSA-N 0.000 description 1
- AUJAZQJUQBHUNI-UHFFFAOYSA-N 1-(3-methylphenyl)piperazine;hydrochloride Chemical compound Cl.CC1=CC=CC(N2CCNCC2)=C1 AUJAZQJUQBHUNI-UHFFFAOYSA-N 0.000 description 1
- OAKNOZRKCYXKAS-UHFFFAOYSA-N 1-(5-methyl-1-pyrimidin-2-ylpyrazol-4-yl)-3-(4-phenylpiperazin-1-yl)propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C=CC=CC=2)C=NN1C1=NC=CC=N1 OAKNOZRKCYXKAS-UHFFFAOYSA-N 0.000 description 1
- BJTXIDOIYZMHAQ-UHFFFAOYSA-N 1-[1-(4-methoxy-6-methylpyrimidin-2-yl)-5-methylpyrazol-4-yl]-3-[4-(2-methylphenyl)piperazin-1-yl]propan-1-one;hydrochloride Chemical compound Cl.COC1=CC(C)=NC(N2C(=C(C(=O)CCN3CCN(CC3)C=3C(=CC=CC=3)C)C=N2)C)=N1 BJTXIDOIYZMHAQ-UHFFFAOYSA-N 0.000 description 1
- PXAZLTYMTHTEMM-UHFFFAOYSA-N 1-[1-(4-methoxy-6-methylpyrimidin-2-yl)-5-methylpyrazol-4-yl]ethanone Chemical compound COC1=CC(C)=NC(N2C(=C(C(C)=O)C=N2)C)=N1 PXAZLTYMTHTEMM-UHFFFAOYSA-N 0.000 description 1
- DZRDXYLQQRXVNR-UHFFFAOYSA-N 1-[1-(4-methoxypyrimidin-2-yl)-5-methylpyrazol-4-yl]ethanone Chemical compound COC1=CC=NC(N2C(=C(C(C)=O)C=N2)C)=N1 DZRDXYLQQRXVNR-UHFFFAOYSA-N 0.000 description 1
- DGNLGWJZZZOYPT-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]piperazin-1-ium;chloride Chemical compound [Cl-].FC(F)(F)C1=CC=CC(N2CC[NH2+]CC2)=C1 DGNLGWJZZZOYPT-UHFFFAOYSA-N 0.000 description 1
- CKRKEONBCXBYNF-UHFFFAOYSA-N 1-[5-methyl-1-(4-methylpyrimidin-2-yl)pyrazol-4-yl]ethanone Chemical compound CC1=C(C(=O)C)C=NN1C1=NC=CC(C)=N1 CKRKEONBCXBYNF-UHFFFAOYSA-N 0.000 description 1
- XQVSONPKJXNWJO-UHFFFAOYSA-N 1-pyridin-2-ylpiperazin-1-ium;chloride Chemical compound Cl.C1CNCCN1C1=CC=CC=N1 XQVSONPKJXNWJO-UHFFFAOYSA-N 0.000 description 1
- AVYGCQXNNJPXSS-UHFFFAOYSA-N 2,5-dichloroaniline Chemical compound NC1=CC(Cl)=CC=C1Cl AVYGCQXNNJPXSS-UHFFFAOYSA-N 0.000 description 1
- YNOOQIUSYGWMSS-UHFFFAOYSA-N 2,5-difluoroaniline Chemical compound NC1=CC(F)=CC=C1F YNOOQIUSYGWMSS-UHFFFAOYSA-N 0.000 description 1
- BETBCTULGKILCZ-UHFFFAOYSA-N 2-(3-bromophenyl)-1,3-thiazole Chemical compound BrC1=CC=CC(C=2SC=CN=2)=C1 BETBCTULGKILCZ-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- KQOIBXZRCYFZSO-UHFFFAOYSA-N 3,5-difluoroaniline Chemical compound NC1=CC(F)=CC(F)=C1 KQOIBXZRCYFZSO-UHFFFAOYSA-N 0.000 description 1
- SSFWCKHABOICGQ-UHFFFAOYSA-N 3-[4-(2,3-dichlorophenyl)piperazin-1-yl]-1-[1-(4,6-dimethylpyrimidin-2-yl)-5-methylpyrazol-4-yl]propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C(=C(Cl)C=CC=2)Cl)C=NN1C1=NC(C)=CC(C)=N1 SSFWCKHABOICGQ-UHFFFAOYSA-N 0.000 description 1
- VOQDMQFHSLKHDO-UHFFFAOYSA-N 3-[4-(2,5-dichlorophenyl)piperazin-1-yl]-1-[1-(4,6-dimethylpyrimidin-2-yl)-5-methylpyrazol-4-yl]propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C(=CC=C(Cl)C=2)Cl)C=NN1C1=NC(C)=CC(C)=N1 VOQDMQFHSLKHDO-UHFFFAOYSA-N 0.000 description 1
- JUCODRVWMDSVNO-UHFFFAOYSA-N 3-[4-(2-chlorophenyl)piperazin-1-yl]-1-(5-methyl-1-pyrimidin-2-ylpyrazol-4-yl)propan-1-ol Chemical compound CC1=C(C(O)CCN2CCN(CC2)C=2C(=CC=CC=2)Cl)C=NN1C1=NC=CC=N1 JUCODRVWMDSVNO-UHFFFAOYSA-N 0.000 description 1
- COJAQTMDRFJWBL-UHFFFAOYSA-N 3-[4-(2-chlorophenyl)piperazin-1-yl]-1-(5-methyl-1-pyrimidin-2-ylpyrazol-4-yl)propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C(=CC=CC=2)Cl)C=NN1C1=NC=CC=N1 COJAQTMDRFJWBL-UHFFFAOYSA-N 0.000 description 1
- DOSKQXVNNDAQAL-UHFFFAOYSA-N 3-[4-(2-chlorophenyl)piperazin-1-yl]-1-[1-(4,6-dimethylpyrimidin-2-yl)-5-methylpyrazol-4-yl]propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C(=CC=CC=2)Cl)C=NN1C1=NC(C)=CC(C)=N1 DOSKQXVNNDAQAL-UHFFFAOYSA-N 0.000 description 1
- JUGZMFSZLQGJJC-UHFFFAOYSA-N 3-[4-(2-methylphenyl)piperazin-1-yl]-1-(5-methyl-1-pyrimidin-2-ylpyrazol-4-yl)propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C(=CC=CC=2)C)C=NN1C1=NC=CC=N1 JUGZMFSZLQGJJC-UHFFFAOYSA-N 0.000 description 1
- QZFKEKVQRZTIOY-UHFFFAOYSA-N 3-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1-[1-(4,6-dimethylpyrimidin-2-yl)-5-methylpyrazol-4-yl]propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C=C(Cl)C(Cl)=CC=2)C=NN1C1=NC(C)=CC(C)=N1 QZFKEKVQRZTIOY-UHFFFAOYSA-N 0.000 description 1
- FRHZLLOCJRJYMZ-UHFFFAOYSA-N 3-[4-(3,5-dichlorophenyl)piperazin-1-yl]-1-(5-methyl-1-pyrimidin-2-ylpyrazol-4-yl)propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C=C(Cl)C=C(Cl)C=2)C=NN1C1=NC=CC=N1 FRHZLLOCJRJYMZ-UHFFFAOYSA-N 0.000 description 1
- UBHMPVLVPATDMN-UHFFFAOYSA-N 3-[4-(3,5-dichlorophenyl)piperazin-1-yl]-1-[1-(4,6-dimethylpyrimidin-2-yl)-5-methylpyrazol-4-yl]propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C=C(Cl)C=C(Cl)C=2)C=NN1C1=NC(C)=CC(C)=N1 UBHMPVLVPATDMN-UHFFFAOYSA-N 0.000 description 1
- RJWVFKIYDPDYMZ-UHFFFAOYSA-N 3-[4-(3-chlorophenyl)piperazin-1-yl]-1-(5-methyl-1-pyrimidin-2-ylpyrazol-4-yl)propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C=C(Cl)C=CC=2)C=NN1C1=NC=CC=N1 RJWVFKIYDPDYMZ-UHFFFAOYSA-N 0.000 description 1
- HHNBBNXHXDVDFB-UHFFFAOYSA-N 3-[4-(3-chlorophenyl)piperazin-1-yl]-1-[1-(4-methoxypyrimidin-2-yl)-5-methylpyrazol-4-yl]propan-1-one;hydrochloride Chemical compound Cl.COC1=CC=NC(N2C(=C(C(=O)CCN3CCN(CC3)C=3C=C(Cl)C=CC=3)C=N2)C)=N1 HHNBBNXHXDVDFB-UHFFFAOYSA-N 0.000 description 1
- MMERRUCVYKTNCB-UHFFFAOYSA-N 3-[4-(4-fluorophenyl)piperazin-1-yl]-1-(5-methyl-1-pyrimidin-2-ylpyrazol-4-yl)propan-1-one;hydrochloride Chemical compound Cl.CC1=C(C(=O)CCN2CCN(CC2)C=2C=CC(F)=CC=2)C=NN1C1=NC=CC=N1 MMERRUCVYKTNCB-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- DHYHYLGCQVVLOQ-UHFFFAOYSA-N 3-bromoaniline Chemical compound NC1=CC=CC(Br)=C1 DHYHYLGCQVVLOQ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 101100005766 Caenorhabditis elegans cdf-1 gene Proteins 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical group O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 238000007239 Wittig reaction Methods 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- TXFLGZOGNOOEFZ-UHFFFAOYSA-N bis(2-chloroethyl)amine Chemical compound ClCCNCCCl TXFLGZOGNOOEFZ-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- NWVNXDKZIQLBNM-UHFFFAOYSA-N diphenylmethylpiperazine Chemical compound C1CNCCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 NWVNXDKZIQLBNM-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- HPOKESDSMZRZLC-UHFFFAOYSA-N propan-2-one;hydrochloride Chemical compound Cl.CC(C)=O HPOKESDSMZRZLC-UHFFFAOYSA-N 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Photoreceptors In Electrophotography (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22942294 | 1994-09-26 | ||
| JP13501095 | 1995-06-01 | ||
| PCT/JP1995/001934 WO1996010024A1 (en) | 1994-09-26 | 1995-09-25 | Pyrimidinylpyrazole derivative |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO971384D0 NO971384D0 (no) | 1997-03-24 |
| NO971384L NO971384L (no) | 1997-05-23 |
| NO313196B1 true NO313196B1 (no) | 2002-08-26 |
Family
ID=26468965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19971384A NO313196B1 (no) | 1994-09-26 | 1997-03-24 | Pyrimidinylpyrazol-derivat, og antitumormiddel inneholdende dette |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5852019A (cs) |
| EP (1) | EP0784055B1 (cs) |
| KR (1) | KR100388568B1 (cs) |
| CN (1) | CN1071754C (cs) |
| AT (1) | ATE232528T1 (cs) |
| CA (1) | CA2201110A1 (cs) |
| DE (2) | DE69529619D1 (cs) |
| DK (1) | DK0784055T3 (cs) |
| ES (1) | ES2192584T3 (cs) |
| FI (1) | FI971227A (cs) |
| HK (1) | HK1001396A1 (cs) |
| NO (1) | NO313196B1 (cs) |
| TW (1) | TW312694B (cs) |
| WO (1) | WO1996010024A1 (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6169086B1 (en) | 1997-01-27 | 2001-01-02 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivatives |
| EA002101B1 (ru) * | 1997-01-27 | 2001-12-24 | Дайити Фармасьютикал Ко., Лтд. | Производные пиразола |
| WO2000005230A1 (fr) * | 1998-07-24 | 2000-02-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de pyrazole et sels correspondants |
| JP4709388B2 (ja) * | 1999-01-25 | 2011-06-22 | 全薬工業株式会社 | 複素環式化合物及びそれを有効成分とする抗腫瘍剤 |
| DK1389617T3 (da) | 2001-04-27 | 2007-05-07 | Zenyaku Kogyo Kk | Heterocyclisk forbindelse og antitumormiddel indeholdende denne som den aktive bestanddel |
| US7109204B2 (en) * | 2001-08-01 | 2006-09-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| FR2850379B1 (fr) * | 2003-01-28 | 2006-11-17 | Aventis Pharma Sa | Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation |
| AU2004218260A1 (en) * | 2003-01-28 | 2004-09-16 | Aventis Pharma S.A. | N-aryl heteroaromatic products, compositions containing same and use thereof |
| US20050130989A1 (en) * | 2003-01-28 | 2005-06-16 | Aventis Pharma S. A. | N-arylheteroaromatic products compositions containing them and use thereof |
| US7223759B2 (en) * | 2003-09-15 | 2007-05-29 | Anadys Pharmaceuticals, Inc. | Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds |
| CA2561406C (en) | 2004-03-31 | 2012-07-03 | Zenyaku Kogyo Kabushiki Kaisha | Heterocyclic compound and anti-malignant-tumor agent comprising the same as effective component |
| SI1864665T1 (sl) * | 2005-03-11 | 2012-09-28 | Zenyaku Kogyo Kk | Imunosupresivno sredstvo, ki obsega heterociklično spojino kot učinkovino |
| US20070244110A1 (en) * | 2006-04-14 | 2007-10-18 | Zenyaku Kogyo Kabushiki Kaisha | Treatment of prostate cancer, melanoma or hepatic cancer |
| EP2079728B1 (en) | 2006-10-10 | 2013-09-25 | Amgen Inc. | N-aryl pyrazole compounds for use against diabetes |
| EP3285581B1 (en) | 2015-03-26 | 2021-08-11 | Merck Sharp & Dohme Corp. | Pyrazolyl pyrimidinone compounds as pde2 inhibitors |
| WO2017059191A1 (en) | 2015-09-30 | 2017-04-06 | Quartet Medicine, Inc. | Heteroaryl derivatives as sepiapterin reductase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3778433A (en) * | 1969-04-18 | 1973-12-11 | Sumitomo Chemical Co | Process for producing benzodiazepine derivatives |
| JPS4842072A (cs) * | 1971-09-29 | 1973-06-19 | ||
| JPS61129129A (ja) * | 1984-11-28 | 1986-06-17 | Kureha Chem Ind Co Ltd | 抗腫瘍剤 |
| US5102893A (en) * | 1986-07-07 | 1992-04-07 | Warner-Lambert Company | Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
-
1995
- 1995-09-19 TW TW084109880A patent/TW312694B/zh active
- 1995-09-25 WO PCT/JP1995/001934 patent/WO1996010024A1/ja active IP Right Grant
- 1995-09-25 AT AT95932229T patent/ATE232528T1/de not_active IP Right Cessation
- 1995-09-25 KR KR1019970701964A patent/KR100388568B1/ko not_active IP Right Cessation
- 1995-09-25 EP EP95932229A patent/EP0784055B1/en not_active Expired - Lifetime
- 1995-09-25 ES ES95932229T patent/ES2192584T3/es not_active Expired - Lifetime
- 1995-09-25 DK DK95932229T patent/DK0784055T3/da active
- 1995-09-25 CA CA002201110A patent/CA2201110A1/en not_active Abandoned
- 1995-09-25 DE DE69529619A patent/DE69529619D1/de not_active Expired - Fee Related
- 1995-09-25 DE DE69529619T patent/DE69529619T4/de not_active Expired - Lifetime
- 1995-09-25 CN CN95196449A patent/CN1071754C/zh not_active Expired - Fee Related
- 1995-09-25 US US08/821,076 patent/US5852019A/en not_active Expired - Fee Related
-
1997
- 1997-03-24 FI FI971227A patent/FI971227A/fi unknown
- 1997-03-24 NO NO19971384A patent/NO313196B1/no not_active IP Right Cessation
-
1998
- 1998-01-12 HK HK98100241A patent/HK1001396A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO971384L (no) | 1997-05-23 |
| CA2201110A1 (en) | 1996-04-04 |
| DE69529619D1 (en) | 2003-03-20 |
| CN1166833A (zh) | 1997-12-03 |
| NO971384D0 (no) | 1997-03-24 |
| EP0784055A1 (en) | 1997-07-16 |
| US5852019A (en) | 1998-12-22 |
| EP0784055A4 (en) | 1998-01-07 |
| KR100388568B1 (ko) | 2003-10-04 |
| KR970706275A (ko) | 1997-11-03 |
| ES2192584T3 (es) | 2003-10-16 |
| DE69529619T2 (de) | 2003-12-18 |
| TW312694B (cs) | 1997-08-11 |
| FI971227A (fi) | 1997-05-23 |
| EP0784055B1 (en) | 2003-02-12 |
| WO1996010024A1 (en) | 1996-04-04 |
| CN1071754C (zh) | 2001-09-26 |
| DE69529619T4 (de) | 2005-01-27 |
| DK0784055T3 (da) | 2003-06-02 |
| ATE232528T1 (de) | 2003-02-15 |
| HK1001396A1 (en) | 1998-06-19 |
| FI971227A0 (fi) | 1997-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU677644B2 (en) | Piperazine derivatives | |
| CA2297326C (en) | Heterocyclic compound and antitumor agent containing the same as active component | |
| NO313196B1 (no) | Pyrimidinylpyrazol-derivat, og antitumormiddel inneholdende dette | |
| US5322844A (en) | Alkoxy-4 (1H)-pyridone derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| CS208659B2 (en) | Method of making the 1,1,2-triphenylalkalen derivatives | |
| US4059621A (en) | Substituted benzamido propanolamines | |
| RU2168508C2 (ru) | Бензонитрилы и бензофториды, способ их получения, фармацевтическая композиция, способ ее получения | |
| RU2116297C1 (ru) | Производные 1,3-замещенного циклоалкена и циклоалкана в форме смеси изомеров или отдельных изомеров, или их гидраты, или соли | |
| US5001134A (en) | Piperidines, processes of preparation and medications containing them | |
| JPWO2004037812A1 (ja) | 複素環式化合物及びそれを有効成分とする抗腫瘍剤 | |
| JPWO2005095389A1 (ja) | 複素環式化合物及びそれを有効成分とする抗悪性腫瘍剤 | |
| DK157861B (da) | Analogifremgangsmaade til fremstilling af 4-substituerede fenylalkylimidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf | |
| DE69021823T2 (de) | 3-Aryl-Oxazolidinone, Verfahren zu ihrer Herstellung und ihre Anwendung in der Therapie. | |
| MX2011005367A (es) | Aril piperazinas y su uso como antagonistas alfa 2c. | |
| US6552018B1 (en) | Pyrazole derivatives | |
| AU2012229859C1 (en) | Nitrogen-containing saturated heterocyclic compound | |
| CZ265994A3 (en) | Derivatives of 1-/2h-1-benzopyran-2-on-8-yl/piperazine, process of their preparation pharmaceutical compositions containing thereof as active components and their use | |
| US4443468A (en) | Benzofuran derivatives, process for their preparation and their therapeutic applications | |
| US4086353A (en) | Certain azolinylamino (azolidinylimino) indazoles | |
| DK166584B1 (da) | Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem | |
| HU189666B (en) | Process for producing thiopyrano-pyrimidine derivatives and acid additional salts | |
| GB2120234A (en) | Triazole and imidazole derivates having fungicidal and plant-growth regulating activity | |
| FR2643373A1 (fr) | Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| JPH0948776A (ja) | ピリミジニルピラゾール誘導体 | |
| EP0505481A1 (en) | 2-substituted 4,5-diphenyl-imidazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |